definiens: or means an interactive presentation ( [ whether face - to - face [ * J or via live videoconfe rencing, including over tbe InternetJ ) by a Party 's sales representative, to [ * J one or several medical professional(s ) having prescribing authority in the applicable territory in the Field, as well as to other mutually agreed individual s or entities that have the ability to impact or influence prescribing decisions in the applicable territory in the Field, where the principal objective of such presentation is to emphasize the features and function of such Collaboration Product in the Field in compliance with applicable Laws . A Detail does not include a reminder or sample drop or [ a non - interactive webcast or similar presentation ] . [ * ] 1.35 or means research, pre - clinical and clinical drug development activities pertaining to a Product, including, without limitation, toxicolog y, pharmacology, test method development, stability testing, process development, formulation development, delivery system development, quality assurance and quality control development, statistical analysis, clinical studies ( including pre - and post - approval studies ), regulatory affairs, pharmacovigilance and Regulatory Approval and clinical study regulatory activities ( including regulatory activities directed to obtaining pricing and reimbursement approvals ) . Development shall include development and regulatory activities for additional indications for a Product after Regulatory Approval of such Product, but shall exclude Phase IV Clinical Studies for purposes other than label expansion and Regulatory Approval and post - marketing surveillance activities